Aug 1, 2023 08:00AM

May 31, 2023 08:00AM

May 11, 2023 04:05PM

Apr 27, 2023 08:00AM

Apr 13, 2023 09:17AM

Mar 29, 2023 04:05PM

Feb 9, 2023 08:00AM IntelGenx Announces Research Collaboration with Renowned Neurologist to Evaluate Montelukast VersaFilm® for the Treatment of Parkinson’s Disease

Nov 22, 2022 07:30AM

Nov 10, 2022 04:05PM

Oct 25, 2022 08:00AM

Oct 18, 2022 08:00AM

Sep 8, 2022 08:00AM

Oct 12, 2021 08:00AM

Oct 21, 2020 07:00AM IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol

Aug 13, 2020 04:02PM

Jun 11, 2020 08:00AM

May 27, 2020 08:00AM

May 14, 2020 04:02PM

Apr 6, 2020 08:00AM

Mar 27, 2020 11:46AM

Mar 26, 2020 07:00AM IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial Results

Mar 23, 2020 08:00AM

Jan 15, 2020 08:00AM

Jan 13, 2020 08:00AM

Nov 7, 2019 04:01PM

Oct 22, 2019 08:00AM

Oct 9, 2019 08:00AM

Sep 26, 2019 04:34PM IntelGenx Announces Resubmission of RIZAPORT® New Drug Application

Aug 8, 2019 04:00PM

Jul 10, 2019 08:00AM

Jun 19, 2019 08:00AM

Jun 10, 2019 08:00AM

May 9, 2019 04:00PM

May 8, 2019 07:00AM

Apr 2, 2019 08:00AM IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA

Mar 22, 2019 04:05PM

Feb 14, 2019 08:00AM

Feb 7, 2019 04:00PM

Jan 30, 2019 08:00AM

Jan 23, 2019 08:00AM

Nov 20, 2018 08:00AM

Nov 8, 2018 04:00PM IntelGenx Reports Third Quarter 2018 Financial Results

Oct 31, 2018 08:00AM

Oct 26, 2018 04:02PM

Oct 22, 2018 06:53PM

Oct 4, 2018 08:16AM

Sep 25, 2018 08:00AM

Sep 24, 2018 08:00AM

Jun 19, 2018 08:00AM IntelGenx Announces Notice of Grant of European Patent Covering  Rizaport® VersaFilm™

Jun 6, 2018 08:00AM

322,963 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All